What is the share price of Glenmark Pharmaceuticals
Limited?
Get GLENMARK share value with Latest News,
Volume Breakout, Delivery Volume Percentage, Pivot
Levels, Fibonacci Levels, Camarilla levels and
Candlestick Patterns. Company shares prices keep
fluctuating as per market conditions. There may be
many reasons for the rise and fall of the share price
of stocks. It may be market conditions, it may be
sector & industry reasons and it may be stocks itself
like earnings, order, upgrade or downgrade etc.
GLENMARK share value today is ₹1068.5
24 Apr, 2024 | 03:32PM
What is the Market cap of Glenmark Pharmaceuticals
Limited?
The Market Cap of
Glenmark Pharmaceuticals Limited is
₹30301 Cr As on
24 Apr, 2024 | 03:32PM. Market capitalization,
or market cap, is the total value of a company's
shares of stock. It is one measurement of a company's
size. A high market cap signifies that the company has
a larger presence in the market. Larger companies may
have less growth potential compares to start-up firms.
Market capitalization refers to how much a company is
worth as determined by the stock market. It is defined
as the total market value of all outstanding shares.
To calculate a company's market cap, multiply the
number of outstanding shares by the current market
value of one share.
What is the PE ratio of Glenmark Pharmaceuticals
Limited?
The P/E ratio of
Glenmark Pharmaceuticals Limited is 0 As
on 24 Apr, 2024 | 03:32PM. Price to Earnings
Ratio or Price to Earnings Multiple is the ratio of
share price of a stock to its earnings per share
(EPS). PE ratio is one of the most popular valuation
metric of stocks. Typically, the average P/E ratio is
around 20 to 25. In general, a high P/E suggests that
investors are expecting higher earnings growth in the
future compared to companies with a lower P/E. A low
P/E can indicate either that a company may currently
be undervalued or that the company growth has stagnant
due to its matured stage.
What is the 52-week high and 52-week low of Glenmark
Pharmaceuticals Limited?
A 52 week high of
Glenmark Pharmaceuticals Limited is
₹1074.6 while 52 week low is ₹507.4. A
52 week high, as the name suggests, is the highest
price that the security/stock has traded over a 52
week period i.e. a year. Similarly 52 week low is the
lowest price that stock has traded over a 52 week
period. It is a technical indicator that is used to
analyse the security's current price. The 52 week high
and 52 week low are also used to predict future
movements as well. 52 week is bullish signal and 52
week low is bearish signal.
What is Support price of Glenmark Pharmaceuticals
Limited?
First support of
Glenmark Pharmaceuticals Limited is
₹1022.02
Second support of
Glenmark Pharmaceuticals Limited is
₹1006.38
Third support of
Glenmark Pharmaceuticals Limited is
₹995.27
Traders use support to plan entry.
Support is the level at which demand is strong enough
to stop the stock from falling any further. Support is
specific point on chart at which maximum buiying
occurs.
What is Resistance price of Glenmark Pharmaceuticals
Limited?
First resistance of
Glenmark Pharmaceuticals Limited is
₹1048.77
Second resistance of
Glenmark Pharmaceuticals Limited is
₹1059.88
Third resistance of
Glenmark Pharmaceuticals Limited is
₹1075.52
Traders use resistance to plan
exit of trade. Resistance is the level at which
selling is strong enough to stop the stock from moving
up any further. Resistance is specific point on chart
at which maximum selling occurs.
What is Glenmark Pharmaceuticals Limited share price
target 2024?
First target of
Glenmark Pharmaceuticals Limited is
₹992.33
Second target of
Glenmark Pharmaceuticals Limited is
₹1028.67
Third target of
Glenmark Pharmaceuticals Limited is
₹1083.33
What is Glenmark Pharmaceuticals Limited share price
target 2025?
First target of Glenmark Pharmaceuticals Limited is
₹1310.16
Second target of
Glenmark Pharmaceuticals Limited is
₹1510.71
Third target of
Glenmark Pharmaceuticals Limited is
₹1683.91
What is Glenmark Pharmaceuticals Limited share price
history?
Date |
Open |
High |
Low |
Close |
Volume |
%Chg |
2024-04-22 |
1030 |
1054.1 |
1026.45 |
1039.35 |
260452 |
1.17 |
2024-04-19 |
1032 |
1039.45 |
1020.15 |
1026.4 |
762705 |
-1.3 |
2024-04-18 |
1060 |
1063.95 |
1034.2 |
1041.8 |
1139830 |
-1.63 |
2024-04-16 |
1044 |
1063.95 |
1040.1 |
1060 |
425482 |
1.53 |
2024-04-15 |
1031 |
1060 |
1031 |
1044 |
586620 |
-0.76 |
2024-04-12 |
1043.35 |
1070 |
1031 |
1051.8 |
980800 |
0.93 |
2024-04-10 |
1047 |
1058 |
1031.55 |
1043.35 |
1178980 |
-0.33 |
2024-04-08 |
1017.4 |
1057.75 |
1017.4 |
1039.1 |
870099 |
2.22 |
2024-04-05 |
1010 |
1019 |
999.3 |
1017.4 |
442664 |
1.18 |
2024-04-04 |
999.45 |
1010 |
990.1 |
1006 |
861431 |
1.08 |
Historical share price of stock is needed to find
the trend of stock, performance analysis of stock
price. History of share price is also used to find
the demand and supply by analyzing volume data if
available.
What is the ROE (Return on Equity) of Glenmark
Pharmaceuticals Limited?
The ROE of Glenmark Pharmaceuticals Limited is
3.08% . Return on equity (ROE) is the measure
of a company's net income divided by its shareholders'
equity. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits. The higher the ROE, the better a company. A
return on equity ratio of 15% to 20% is usually
considered good. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits.
What is the Earning per Share (EPS) of Glenmark
Pharmaceuticals Limited?
The EPS of Glenmark Pharmaceuticals Limited is
₹-25.22. Earnings per share (EPS) is a
company's net profit divided by the number of common
shares it has outstanding. EPS indicates how much
money a company makes for each share of its stock.
There's no fixed answer for what is a good EPS. When
comparing companies, it's helpful to look closely at
how EPS is trending and how it matches up to
competitor earnings. Remember that a higher EPS can
suggest growth and stock price increases.
What is the ROCE of Glenmark Pharmaceuticals Limited?
The ROCE of Glenmark Pharmaceuticals Limited is
8.53%. Return on capital employed is a
financial ratio that measures a company's
profitability in terms of all of its capital. ROCE is
similar to return on invested capital. It's always a
good idea to compare the ROCE of companies in the same
industry. The higher the ROCE, the better it is. The
ratio calculated as 20% is considered good, indicating
the company is more profitable and has a stable
financial position in the market.
What is the NPM (Net profit margin) of Glenmark
Pharmaceuticals Limited?
The NPM of Glenmark Pharmaceuticals Limited is
2.23%. Net Profit Margin is a financial ratio
used to calculate the percentage of profit a company
produces from its total revenue. Net profit margin
helps investors assess if a company's management is
generating enough profit from its sales and whether
operating costs and overhead costs are under control.
What is EBITDA of Glenmark Pharmaceuticals Limited?
The EBITDA of
Glenmark Pharmaceuticals Limited is
13.75%. EBITDA stands for Earnings Before
Interest, Taxes, Depreciation, and Amortization. It is
the alternate method of measuring profitability in net
income. EBITDA is useful when comparing companies with
different capital investment, debt, and tax
profiles.This key profitability measure is one of the
main measures of a company's financial health and
ability to generate cash. It is one of the most widely
used measures of a company's financial health and
ability to generate cash.
What is Debt to Equity ratio (D/E Ratio) of Glenmark
Pharmaceuticals Limited?
The debt to equity ratio of
Glenmark Pharmaceuticals Limited is
47.03. The debt-to-equity ratio (D/E ratio)
shows how much debt a company has compared to its
assets. It is found by dividing a company's total debt
by total shareholder equity. Generally, a good debt to
equity ratio is around 1 to 1.5. However, the ideal
debt to equity ratio will vary depending on the
industry, as some industries use more debt financing
than others. A higher D/E ratio means the company may
have a harder time covering its liabilities. It will
be very hard if the economic scenario worsens.
What is Glenmark Pharmaceuticals Limited news today?
Glenmark Pharmaceuticals Limited share news
: LTP 1068.5
%Chg: 3.29
Chg: 34
Volume: 530457
Get detailed Glenmark Pharmaceuticals Limited
share price news, analysis, Dividend, Quarterly
results, Fundamentals & more information.
Today’s Glenmark Pharmaceuticals Limited screener
scan?
Get the last 5 days of Glenmark Pharmaceuticals
Limited share screener at "ALL SCAN" feature of Money
Tree Robo with recommended price for buying & selling.
Also find the trend of Glenmark Pharmaceuticals
Limited share price screener after recommendation.
What is Glenmark Pharmaceuticals Limited share price
target?
Glenmark Pharmaceuticals Limited share price
target today:
First target of Glenmark Pharmaceuticals Limited
share is ₹1068.86.
Second target of Glenmark Pharmaceuticals Limited
share is ₹1071.09.
Third target of Glenmark Pharmaceuticals Limited
share is ₹1077.78.